A systematic screening to identify de novo mutations causing sporadic early-onset Parkinson's disease.
Ontology highlight
ABSTRACT: Despite the many advances in our understanding of the genetic basis of Mendelian forms of Parkinson's disease (PD), a large number of early-onset cases still remain to be explained. Many of these cases, present with a form of disease that is identical to that underlined by genetic causes, but do not have mutations in any of the currently known disease-causing genes. Here, we hypothesized that de novo mutations may account for a proportion of these early-onset, sporadic cases. We performed exome sequencing in full parent-child trios where the proband presents with typical PD to unequivocally identify de novo mutations. This approach allows us to test all genes in the genome in an unbiased manner. We have identified and confirmed 20 coding de novo mutations in 21 trios. We have used publicly
SUBMITTER: Kun-Rodrigues C
PROVIDER: S-EPMC4634375 | biostudies-literature | 2015 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA